source
- Akeso CEO says biliary tract cancer data could be a breakthroughAkeso’s chief executive Michelle Xia told ChinaPharma that the company’s PD-1xVEGF bispecific antibody, ivonescimab, is generating strong interest after early biliary tract cancer results. She not…
- Metriport secures $26 million Series A to streamline doctor access to patient dataMetriport, a health-tech startup focused on simplifying how physicians obtain patient information, announced a $26 million Series A financing. The round was led by Matrix, with participation from…